Paul Britton is a notable inventor based in Woking, GB. He has made significant contributions to the field of virology, particularly in the development of vaccines for infectious diseases. With a total of 4 patents to his name, Britton's work is pivotal in advancing medical science.

Latest Patents

Among his latest patents, Britton has developed a live, attenuated coronavirus that includes a mutation in non-structural protein nsp-3 and/or deletion of accessory proteins 3a and 3b. This innovation may serve as a vaccine for treating and preventing diseases such as infectious bronchitis in subjects. Another significant patent involves a live, attenuated coronavirus featuring a variant replicase gene that encodes polyproteins with mutations in non-structural proteins nsp-10, nsp-14, nsp-15, or nsp-16. This invention also aims to provide a vaccine for infectious bronchitis.

Career Highlights

Paul Britton is associated with The Pirbright Institute, where he conducts his research and development work. His expertise in virology and vaccine development has positioned him as a key figure in the scientific community.

Collaborations

Britton collaborates with esteemed colleagues, including Erica Bickerton and Sarah Keep, to further enhance the impact of his research.

Conclusion

Paul Britton's innovative work in the field of coronavirus vaccine development showcases his dedication to improving public health. His contributions are vital in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.